Basit öğe kaydını göster

Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination

dc.contributor.authorYenen, Osman Şadi
dc.contributor.authorSaribas, Suat
dc.contributor.authorYuksel, Pelin
dc.contributor.authorAlan, Esra
dc.contributor.authorKocazeybek, Bekir
dc.contributor.authorAltunay, Husnu
dc.contributor.authorKosan, Erdogan
dc.contributor.authorBirinci, Ilhan
dc.contributor.authorAksoy, Armagan
dc.contributor.authorKirali, Kaan
dc.contributor.authorAslan, Mustafa
dc.date.accessioned2021-03-06T13:05:58Z
dc.date.available2021-03-06T13:05:58Z
dc.date.issued2010
dc.identifier.citationAltunay H., Kosan E., Birinci I., Aksoy A., Kirali K., Saribas S., Aslan M., Yuksel P., Alan E., Yenen O. Ş. , et al., "Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination", TRANSFUSION AND APHERESIS SCIENCE, cilt.43, ss.265-268, 2010
dc.identifier.issn1473-0502
dc.identifier.othervv_1032021
dc.identifier.otherav_f700ddb1-5406-4953-b713-ce6d3a51eaa4
dc.identifier.urihttp://hdl.handle.net/20.500.12627/161834
dc.identifier.urihttps://doi.org/10.1016/j.transci.2010.09.012
dc.description.abstractAim: Hepatitis B virus (HBV) can be transmitted by blood transfusions even so using serological tests having high sensitivity and specificity. We aimed to detect HBV DNA in isolated Anti-HBc donors and show if they have transfusion risk or not.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleAre isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination
dc.typeMakale
dc.relation.journalTRANSFUSION AND APHERESIS SCIENCE
dc.contributor.departmentKizilay Dernegi , ,
dc.identifier.volume43
dc.identifier.issue3
dc.identifier.startpage265
dc.identifier.endpage268
dc.contributor.firstauthorID3846


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster